Login to Your Account



Search

Search results

U.S. Patent Disclosures

No Abstract (BioWorld Today, BioWorld-Today-2005-08-15) ...

BioWorld Today - Staff - 2005-08-14 23:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

No Abstract (BioWorld Today, BioWorld-Today-2002-06-19) ...

BioWorld Today - Staff - 2002-06-18 23:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

No Abstract (BioWorld Today, BioWorld-Today-2000-05-10) ...

BioWorld Today - Staff - 2000-05-09 23:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

No Abstract (BioWorld Today, BioWorld-Today-2001-12-20) ...

BioWorld Today - Staff - 2001-12-20 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

• BioChemics Inc. , of Danvers, Mass., was issued U.S. Patent No. 8,343,486, "Methods and Composition for Topical Treatment of Medical Conditions Including Wounds and Inflammation"; and No. 8,354,116, "Bifunctional Synthetic Mole ...

BioWorld Today - Staff - 2013-02-15 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

No Abstract Novosom AG , of Halle, Germany, received U.S. Patent No. 7,371,404, titled "Amphoteric liposomes and their use." It covers Smarticles, which are fully charged reversible liposomes for the in vivo delivery of nucleotides such as siRNA ...

BioWorld Today - Staff - 2008-07-31 23:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

• Celladon Corp. , of San Diego, was issued a notice of allowance for U.S. Patent application No. 13/145,787, "Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium ATPase and phosphlamban." (BioWorld-Today-20 ...

BioWorld Today - Staff - 2013-02-07 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

• Curis Inc. , of Lexington, Mass., was issued U.S. Patent No. 8,324,240, "Fused Amino Pyridine as HSP90 Inhibitors," for a genus of compounds, which include Debio 0932, a heat-shock protein 90 inhibitor. (BioWorld-Today-2013 ...

BioWorld Today - Staff - 2013-01-17 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

• Lithera Inc. , of San Diego, was issued a notice of allowance for its U.S. patent application, related to LIPO-202 (Salmeterol Xinafoate for Injection). LIPO-202 is being developed for selective, nonablative, local fat reduction. (Bi ...

BioWorld Today - Staff - 2013-01-18 00:00 - 0 comments - 0 attachments

U.S. Patent Disclosures

No Abstract (BioWorld Today, BioWorld-Today-2002-05-15) ...

BioWorld Today - Staff - 2002-05-14 23:00 - 0 comments - 0 attachments